Argent Biopharma Limited has released a press release.
US$550,000 Convertible Note Facility Funding
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Argent Biopharma
- Interim Results - CimetrA Dosing Finding Study
- US$750,000 Convertible Note Facility Funding
- AMC Holdings Inc places US$1 million ArtemiC order
- Study Results - Effects of CannEpil on driving performance
- US$1.2M Tranche 1 Funding Recevied from Mercer
Later from Argent Biopharma
- TGA advertising Infringement Notice
- Appointment of UK Corporate Advisor and Company Update
- Operations Update
- Pause in Trading
- Long COVID study Results
Follow Argent Biopharma into a list and get an email when it puts out news.
Follow Argent Biopharma